Boston Scientific Corporation (NYSE:BSX)
Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company’s products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.
Boston Scientific Corporation (NYSE:BSX)’s Financial Overview
Boston Scientific Corporation (NYSE:BSX) surged 0.1% yesterday to close its trading session at $20.77. The company has 1 year Price Target of $27.66. Boston Scientific Corporation has 52-Week high of $24.79 and 52-Week Low of $15.67. The stock touched its 52-Week High on Jul 28, 2016 and 52-Week Low on Feb 8, 2016. The stock traded with the volume of 6.96 Million shares yesterday. The firm shows the market capitalization of $28.28 Billion.
Boston Scientific Corporation (NYSE:BSX) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $0.27/share against the analyst consensus estimate of $0.27/share. The difference between the actual and expected EPS is $0 a share with a surprise factor of 0%.
The firm is trading with SMA20 of -3.25 Percent, SMA50 of -7.67 Percent and SMA200 of -4.85 percent. Boston Scientific Corporation has P/S value of 3.46 while its P/B value stands at 4.36. Similarly, the company has Return on Assets of 0.5 percent, Return on Equity of 1.3 percent and Return on Investment of 0.7 Percent. The company shows Gross Margin and Operating Margin of 71.3 percent and 0.4 percent respectively.
Many brokerage firms are involved in issuing their ratings on Boston Scientific Corporation (NYSE:BSX). On 1-Sep-16 Argus Upgrade Boston Scientific Corporation Stock to Buy. Another firm also rated the stock on 9-Jun-16 where Guggenheim Initiated the stock to Buy.
The Stock currently has Analyst’ mean Recommendation of 1.8 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 24 analysts offering 12-month price forecasts for Boston Scientific Corp have a median target of 28.00, with a high estimate of 31.00 and a low estimate of 20.00. The median estimate represents a +34.81% increase from the last price of 20.77.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
The Charles Schwab Corporation (NYSE:SCHW)
Charles Schwab Corp. provides a full-service investing experience to customers through a clicks and mortar multi-dimensional, five channel offering of the Internet, branch offices, speech recognition, touch-tone telephone, e-mail and wireless technologies, multilingual and international services, and direct access to professionals day or night.
The Charles Schwab Corporation (NYSE:SCHW)’s Financial Outlook
The 18 analysts offering 12-month price forecasts for Charles Schwab have a median target of 36.00, with a high estimate of 42.00 and a low estimate of 29.00. The median estimate represents a -6.40% decrease from the last price of 38.46.
The Charles Schwab Corporation is estimated to report earnings on 01/17/2017. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 11 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.35. The reported EPS for the same quarter last year was $0.25.
According to Zacks Investment Research, The Charles Schwab Corporation has a Consensus Recommendation of 1.68. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock gained 0.29% and closed its last trading session at $38.46. The company has the market capitalization of $50.99 Billion. The stock has 52-week high of $39.22 and 52-Week low of $21.51. The firm touched its 52-Week high on Nov 23, 2016 and 52-Week low on Feb 11, 2016. The company has volume of 6.96 Million shares. The company has a total of 1.33 Billion shares outstanding.
The Charles Schwab Corporation (NYSE:SCHW) in the last quarter reported its actual EPS of $0.35/share where the analyst estimated EPS was $0.33/share. The difference between the actual and Estimated EPS is $0.02. This shows a surprise factor of 6.1 percent.
The company has YTD performance of 17.92 percent. Beta for The Charles Schwab Corporation stands at 1.75 while its ATR (average true range) is 0.84. The company has Weekly Volatility of 1.64%% and Monthly Volatility of 2.38%%.
The Charles Schwab Corporation has distance from 20-day Simple Moving Average (SMA20) of 9.3%, Distance from 50-Day Simple Moving Average of 16.4 percent and Distance from 200-Day Simple Moving Average of 31.09%.
The Company currently has ROA (Return on Assets) of 0.8 percent, Return on Equity (ROE) of 13.1 Percent and Return on Investment (ROI) of 1% with Gross margin of 97.8 percent and Operating & Profit margin of 38.3% and 22.4% respectively.